@WSJ 3 years ago The FDA could authorize Pfizer's Covid-19 booster for 16- and 17-year-olds as soon as next week, according to a person familiar with the planning on.wsj.com
@realclearpolitics.com 5 years ago Blame America or China? A Dilemma for Democrats